These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

602 related articles for article (PubMed ID: 19595185)

  • 41. [Experience in resection of hilar cholangiocarcinoma: a report of 54 cases].
    Jiang HC; Sun B; Lu ZY; Meng QH; Wu LF; Xu J; Wang FJ
    Zhonghua Wai Ke Za Zhi; 2006 Apr; 44(7):441-4. PubMed ID: 16772075
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Application of portal parenchyma-enterostomy after high hilar resection for Bismuth type IV hilar cholangiocarcinoma.
    Cheng Y; Chen Y; Chen H
    Am Surg; 2010 Feb; 76(2):182-7. PubMed ID: 20336897
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Does intrahepatic cholangiocarcinoma have better prognosis compared to perihilar cholangiocarcinoma?
    Guglielmi A; Ruzzenente A; Campagnaro T; Pachera S; Valdegamberi A; Capelli P; Pedica F; Nicoli P; Conci S; Iacono C
    J Surg Oncol; 2010 Feb; 101(2):111-5. PubMed ID: 19953578
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Surgical treatment for hilar cholangiocarcinoma of Bismuth-Corlette type IV].
    He Y; Li ZH; Cai JX; Han BL; He ZP; Wang SG; Bie P
    Zhonghua Wai Ke Za Zhi; 2009 Aug; 47(15):1151-4. PubMed ID: 20021906
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Changing trends in surgical outcomes after major hepatobiliary resection for hilar cholangiocarcinoma: a single-center experience over 25 years.
    Sano T; Shimada K; Sakamoto Y; Esaki M; Kosuge T
    J Hepatobiliary Pancreat Surg; 2007; 14(5):455-62. PubMed ID: 17909713
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic significance of lymph node metastasis and surgical margin status for distal cholangiocarcinoma.
    Murakami Y; Uemura K; Hayashidani Y; Sudo T; Hashimoto Y; Ohge H; Sueda T
    J Surg Oncol; 2007 Mar; 95(3):207-12. PubMed ID: 17278119
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Aggressive surgical resection for hilar cholangiocarcinoma: is it justified? Audit of a single center's experience.
    Konstadoulakis MM; Roayaie S; Gomatos IP; Labow D; Fiel MI; Miller CM; Schwartz ME
    Am J Surg; 2008 Aug; 196(2):160-9. PubMed ID: 18466862
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinicopathologic features, diagnosis and surgical treatment of intrahepatic cholangiocarcinoma in 104 patients.
    Fu XH; Tang ZH; Zong M; Yang GS; Yao XP; Wu MC
    Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):279-83. PubMed ID: 15138126
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Analysis of the surgical outcome and prognostic factors for hilar cholangiocarcinoma].
    Li Q; Li HK; Hao XS
    Zhonghua Wai Ke Za Zhi; 2009 Jan; 47(2):94-7. PubMed ID: 19563000
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Surgical treatments for hilar cholangiocarcinoma].
    Liu YB; Jian ZX; Liu ZX; Ou JR
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Dec; 24(12):1401-3. PubMed ID: 15604069
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The clinical presentation and prognostic factors for intrahepatic and extrahepatic cholangiocarcinoma in a tertiary care centre.
    Singal AG; Rakoski MO; Salgia R; Pelletier S; Welling TH; Fontana RJ; Lok AS; Marrero JA
    Aliment Pharmacol Ther; 2010 Mar; 31(6):625-33. PubMed ID: 20003093
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CD10+ fibroblasts are more involved in the progression of hilar/extrahepatic cholangiocarcinoma than of peripheral intrahepatic cholangiocarcinoma.
    Nishihara Y; Aishima S; Hayashi A; Iguchi T; Fujita N; Taketomi A; Honda H; Tsuneyoshi M
    Histopathology; 2009 Oct; 55(4):423-31. PubMed ID: 19817893
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma.
    Kim KH; Lee SG; Park EH; Hwang S; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
    Ann Surg Oncol; 2009 Mar; 16(3):623-9. PubMed ID: 19130133
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Surgical approach in hilar cholangiocarcinoma].
    Otto G
    Zentralbl Chir; 2006 Jun; 131(3):210-6. PubMed ID: 16739061
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinicopathologic study of cholangiocarcinoma with superficial spread.
    Igami T; Nagino M; Oda K; Nishio H; Ebata T; Yokoyama Y; Shimoyama Y
    Ann Surg; 2009 Feb; 249(2):296-302. PubMed ID: 19212185
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diagnosis and treatment of hepatic cholangiocarcinoma: report of 52 cases.
    Guo ZJ; Li Q; He K
    Hepatobiliary Pancreat Dis Int; 2003 Feb; 2(1):62-5. PubMed ID: 14599932
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinicopathological analysis of colorectal cancer liver metastasis and intrahepatic cholangiocarcinoma: are they just apples and oranges?
    Chiu CT; Chiang JM; Yeh TS; Tseng JH; Chen TC; Jan YY; Chen MF
    Dig Liver Dis; 2008 Sep; 40(9):749-54. PubMed ID: 18329969
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aggressive surgical resection for hilar cholangiocarcinoma.
    Lai EC; Lau WY
    ANZ J Surg; 2005 Nov; 75(11):981-5. PubMed ID: 16336393
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical significance of intraoperative bile duct margin assessment for hilar cholangiocarcinoma.
    Endo I; House MG; Klimstra DS; Gönen M; D'Angelica M; Dematteo RP; Fong Y; Blumgart LH; Jarnagin WR
    Ann Surg Oncol; 2008 Aug; 15(8):2104-12. PubMed ID: 18543039
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Improved operative and survival outcomes of surgical treatment for hilar cholangiocarcinoma.
    Liu CL; Fan ST; Lo CM; Tso WK; Lam CM; Wong J
    Br J Surg; 2006 Dec; 93(12):1488-94. PubMed ID: 17048280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.